摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-溴苯基)-2-甲基丙酸 | 32454-35-6

中文名称
2-(4-溴苯基)-2-甲基丙酸
中文别名
4-溴-alpha,alpha-二甲基苯乙酸
英文名称
2-(4-bromophenyl)-2-methylpropanoic acid
英文别名
2-(4-bromophenyl)-2-methylpropionic acid
2-(4-溴苯基)-2-甲基丙酸化学式
CAS
32454-35-6
化学式
C10H11BrO2
mdl
MFCD02684220
分子量
243.1
InChiKey
AKVOQXBQLXOEEF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    122-124°C
  • 沸点:
    334.2±17.0 °C(Predicted)
  • 密度:
    1.456±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于二氯甲烷、乙酸乙酯、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2916399090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温。

SDS

SDS:722913d3b609135f1a981d338f585669
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-(4-Bromophenyl)-2-methylpropanoic acid
Synonyms: 2-(4-Bromophenyl)-2,2-dimethylacetiic acid

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(4-Bromophenyl)-2-methylpropanoic acid
CAS number: 32454-35-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11BrO2
Molecular weight: 243.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-溴苯基)-2-甲基丙酸copper(l) iodide 硫酸potassium carbonate 、 sodium hydroxide 作用下, 以 甲醇甲苯 为溶剂, 反应 58.0h, 生成 非索芬那定
    参考文献:
    名称:
    Preparation of 2-(4-bromophenyl)-2-methylpropanoic acid
    摘要:
    在水介质中进行2-甲基-2-苯基丙酸的选择性溴化,可获得纯的2-(4-溴苯基)-2-甲基丙酸,这是制造纯费索菲尼丁的关键中间体。
    公开号:
    EP2532644A1
  • 作为产物:
    描述:
    alpha,alpha-二甲基苯乙酸碳酸氢钠盐酸 作用下, 以 为溶剂, 反应 13.0h, 以46.6%的产率得到2-(4-溴苯基)-2-甲基丙酸
    参考文献:
    名称:
    PREPARATION OF 2-(4-BROMOPHENYL)-2-METHYLPROPANOIC ACID
    摘要:
    在水介质中进行2-甲基-2-苯基丙酸的选择性溴化,以获得纯的2-(4-溴苯基)-2-甲基丙酸,该化合物是制备纯费索菲尼的关键中间体。
    公开号:
    US20120309973A1
点击查看最新优质反应信息

文献信息

  • [EN] MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES MACROCYCLIQUES À LARGE SPECTRE
    申请人:RQX PHARMACEUTICALS INC
    公开号:WO2018149419A1
    公开(公告)日:2018-08-23
    Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
    本文提供了抗菌化合物,其中在某些实施例中,这些化合物具有广谱生物活性。在各种实施例中,这些化合物通过抑制细菌类型1信号肽酶(SpsB)发挥作用,这是细菌中的一种必需蛋白质。还提供了使用所述化合物的药物组合物和治疗方法。
  • Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors
    作者:Bowen Yang、Qian Wu、Xiajuan Huan、Yingqing Wang、Yin Sun、Yueyue Yang、Tongchao Liu、Xin Wang、Lin Chen、Bing Xiong、Dongmei Zhao、Zehong Miao、Danqi Chen
    DOI:10.1016/j.bmcl.2020.127749
    日期:2021.2
    In an in-house screening, 1H-pyrrolo[2,3-b]pyridine scaffold was found to have high inhibition on TNIK. Several series of compounds were designed and synthesized, among which some compounds had potent TNIK inhibition with IC50 values lower than 1 nM. Some compounds showed concentration-dependent characteristics of IL-2 inhibition. These results provided new applications of TNIK inhibitors and new prospects
    在内部筛选中,发现1 H-吡咯并[2,3- b ]吡啶支架对TNIK具有高度抑制作用。设计并合成了一系列化合物,其中一些化合物具有强的TNIK抑制作用,IC 50值低于1 nM。一些化合物表现出浓度依赖性的IL-2抑制特性。这些结果提供了TNIK抑制剂的新应用以及TNIK作为药物靶标的新前景。
  • Hindered dialkyl ether synthesis with electrogenerated carbocations
    作者:Jinbao Xiang、Ming Shang、Yu Kawamata、Helena Lundberg、Solomon H. Reisberg、Miao Chen、Pavel Mykhailiuk、Gregory Beutner、Michael R. Collins、Alyn Davies、Matthew Del Bel、Gary M. Gallego、Jillian E. Spangler、Jeremy Starr、Shouliang Yang、Donna G. Blackmond、Phil S. Baran
    DOI:10.1038/s41586-019-1539-y
    日期:2019.9.19
    simple route towards the synthesis of hindered ethers, in which electrochemical oxidation is used to liberate high-energy carbocations from simple carboxylic acids. These reactive carbocation intermediates, which are generated with low electrochemical potentials, capture an alcohol donor under non-acidic conditions; this enables the formation of a range of ethers (more than 80 have been prepared here)
    受阻醚在各种应用中都具有很高的价值;然而,它们仍然是未充分探索的化学空间领域,因为它们难以通过常规反应合成 1,2。这种基序在药物化学中非常令人垂涎,因为对醚键的广泛取代可以防止可能导致体内快速降解的不需要的代谢过程。在这里,我们报告了合成受阻醚的简单途径,其中电化学氧化用于从简单的羧酸中释放高能碳正离子。这些反应性碳阳离子中间体以低电化学势生成,在非酸性条件下捕获醇供体;这使得能够形成一系列醚(这里已经制备了 80 多种),否则很难获得。碳正离子也可以被简单的亲核试剂拦截,导致受阻醇甚至烷基化物的形成。评估该方法能够规避制备 12 种化学支架时遇到的合成瓶颈,从而提高所需产品的产率,此外还显着减少了制备所需的步骤数量和劳动量。分子探针的使用和动力学研究的结果支持了所提出的机制和添加剂在所检查条件下的作用。我们在这里报告的反应流形证明了电化学在温和条件下获得高反应性中间体的能力,反过来,
  • Palladium-Catalyzed Distal <i>m</i>-C–H Functionalization of Arylacetic Acid Derivatives
    作者:Dasari Srinivas、Gedu Satyanarayana
    DOI:10.1021/acs.orglett.1c02460
    日期:2021.10.1
    Herein, we present m-C–H olefination on derivatives of phenylacetic acids by tethering with a simple nitrile-based template through palladium catalysis. Notably, the versatility of the method is evaluated with a wide range of phenylacetic acid derivatives for obtaining the meta-olefination products in fair to excellent yields with outstanding selectivities under mild conditions. Significantly, the
    在此,我们通过催化与简单的腈基模板连接,在苯乙酸生物上进行m -C-H 烯化。值得注意的是,该方法的多功能性是用范围广泛的苯乙酸生物来评估的,以便在温和的条件下以中等至极好的收率和出色的选择性获得间烯烃化产物。重要的是,本策略成功地用于合成药物/天然产物类似物(萘普生布洛芬扑热息痛胆固醇)。
  • A donor–acceptor complex enables the synthesis of <i>E</i>-olefins from alcohols, amines and carboxylic acids
    作者:Kun-Quan Chen、Jie Shen、Zhi-Xiang Wang、Xiang-Yu Chen
    DOI:10.1039/d1sc01024g
    日期:——
    Olefins are prevalent substrates and functionalities. The synthesis of olefins from readily available starting materials such as alcohols, amines and carboxylic acids is of great significance to address the sustainability concerns in organic synthesis. Metallaphotoredox-catalyzed defunctionalizations were reported to achieve such transformations under mild conditions. However, all these valuable strategies
    烯烃是普遍的底物和功能。从醇、胺和羧酸等易得起始原料合成烯烃对于解决有机合成中的可持续性问题具有重要意义。据报道,属光氧化还原催化的去官能化可以在温和条件下实现这种转变。然而,所有这些有价值的策略都需要过渡属催化剂、配体或昂贵的光催化剂,并且仍然存在控制区域选择性和立体选择性的挑战。在此,我们提出了一种由电子供体-受体(EDA)配合物实现的根本不同的策略,用于从这些简单且易于获得的起始材料选择性合成烯烃。该转化是通过用碱属盐对活化底物的 EDA 络合物进行光活化,然后从原位生成的烷基自由基中消除氢原子来进行的。该方法操作简单直接,不含光催化剂和过渡属,并表现出高区域选择性和立体选择性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫